Skip to content
Clinical Trial Events
SCOPE Summit for Clinical Ops Executives

Panel Digital Health Technologies track

Driving DHT Adoption and Utility through Advocacy and Multi-Organizational Collaboration

Thu, Feb 6, 2025 · 8:50–9:25 AM EST Rosen Shingle Creek

About this session

Panel Discussion.

Digitally derived measures of health can help unlock a whole new perspective into human health, but developing them is a complex effort needing involvement from multiple stakeholders. This session brings together the entire journey and illustrates the key pitfalls and solutions through real-world examples shared by leaders from key pharmaceutical and technology companies.

Speakers

  • Kai Langel

    CEO · DEEP Measures

    Moderator

  • Martha Azer

    Associate Director · Johnson & Johnson Innovative Medicine

    Panelist

  • Scottie Kern

    Executive Director, eCOA Consortium · Critical Path Institute

    Panelist

  • Carrie A. Northcott

    Director & Project Lead · Pfizer Inc

    Panelist

  • Bola Grace

    Professor · University College London

    Panelist